or Try an Advanced Search...

    Technical Analysis for PTIX - Protagenic Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.90 -0.55% -0.01
    PTIX closed down 0.55 percent on Monday, July 1, 2024, on 63 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PTIX trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bullish Signal Line Cross Bullish -0.55%
    NR7 Range Contraction -0.55%
    Narrow Range Bar Range Contraction -0.55%
    Stochastic Reached Oversold Weakness -0.55%
    Inside Day Range Contraction -0.55%
    Wide Bands Range Expansion -0.55%
    Older End-of-Day Signals for PTIX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    Outside Day about 9 hours ago
    Up 3% about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Down 2 % about 9 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PTIX Chart by TradingView
    Basic chart:

    Profile

    Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunology Mood Disorders Pre Clinical Biopharmaceutical

    Is PTIX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 22 Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders
    Apr 17 Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit
    Apr 1 Earnings Scheduled For April 1, 2024
    Mar 27 Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
    Mar 25 Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
    Feb 13 Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
    See more PTIX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.2
    52 Week Low 0.6797
    Average Volume 16,170
    200-Day Moving Average 1.12
    50-Day Moving Average 1.25
    20-Day Moving Average 1.00
    10-Day Moving Average 0.94
    Average True Range 0.12
    RSI (14) 37.11
    ADX 12.95
    +DI 17.28
    -DI 19.49
    Chandelier Exit (Long, 3 ATRs) 1.14
    Chandelier Exit (Short, 3 ATRs) 1.22
    Upper Bollinger Bands 1.25
    Lower Bollinger Band 0.75
    Percent B (%b) 0.3
    BandWidth 49.53
    MACD Line -0.11
    MACD Signal Line -0.11
    MACD Histogram 0.0033
    Fundamentals Value
    Market Cap 3.99 Million
    Num Shares 4.44 Million
    EPS -0.91
    Price-to-Earnings (P/E) Ratio -0.99
    Price-to-Sales 0.00
    Price-to-Book 1.03
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.01
    Resistance 3 (R3) 1.01 0.97 0.99
    Resistance 2 (R2) 0.97 0.94 0.97 0.99
    Resistance 1 (R1) 0.94 0.93 0.92 0.94 0.98
    Pivot Point 0.90 0.90 0.89 0.90 0.90
    Support 1 (S1) 0.86 0.87 0.84 0.86 0.82
    Support 2 (S2) 0.82 0.85 0.82 0.81
    Support 3 (S3) 0.79 0.82 0.81
    Support 4 (S4) 0.79